Screener
Moderna MRNA Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Moderna in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The source filing: Moderna’s 10-Q, filed May 1, 2026. Open the filing →
- Filed
- May 1, 2026, 4:10 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001682852-26-000060
FAQ
- What is Moderna's operating lease liabilities (current)?
- Moderna (MRNA) reported operating lease liabilities (current) of $19M in Q1 2026.
- How has Moderna's operating lease liabilities (current) changed year-over-year?
- Moderna's operating lease liabilities (current) increased by 26.7% year-over-year, from $15M to $19M.
- What is the long-term trend for Moderna's operating lease liabilities (current)?
- Over 5 years (2020 to 2025), Moderna's operating lease liabilities (current) has grown at a 23.2% compound annual growth rate (CAGR), from $6M to $17M.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.
Ask your AI about Moderna's operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude